---
title: "Animal Health Industry: Companies, KPIs"
description: "Animal health companies develop and sell medicines, vaccines, diagnostics and feed additives for pets and livestock. Pet products follow owner spending."
canonical: https://www.getswoopr.com/stocks/industries/health-care/animal-health/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Animal Health Industry

## Direct Answer

Animal health companies develop and sell medicines, vaccines, diagnostics and feed additives for pets and livestock. Pet products follow owner spending and veterinary visits, while livestock products follow protein demand and disease outbreaks.

## Industry Overview

Animal Health sits within the health care sector. The first numbers to compare across companies here are revenue split between pet and livestock, organic growth in key brands and vet clinic visit trends. The outside forces that move them are listed under Primary Macro Drivers.

## Key Industry Metrics

- **Revenue split between pet and livestock**: Portion of sales from companion animal products versus farm animal products. Pet sales track owner spending and vet visits, livestock sales track protein prices and disease, so the mix shows which cycle is in charge.
- **Organic growth in key brands**: Sales growth of leading products excluding acquisitions and currency effects. It shows whether demand and pricing for core medicines are really expanding or whether growth came from deals.
- **Vet clinic visit trends**: Change in the number of pet visits to veterinary clinics, an early signal for demand for prescribed medicines and diagnostics. Falling visits can weigh on sales even when pet ownership holds steady.
- **Gross margin**: Share of sales left after the direct cost of making medicines and vaccines. A decline can signal generic or compounded competition, a shift toward lower-priced products or higher plant costs.
- **Pipeline of new approvals**: Candidate products awaiting regulatory approval for pet or livestock use. Launches replace sales lost to generics, so a thin pipeline raises the risk that growth fades as older products mature.

## Primary Macro Drivers

- **Pet ownership and spending per pet**: More pets and higher owner spending per pet raise demand for medicines and diagnostics, which shows up in pet revenue and organic growth of key brands.
- **Veterinary visit volumes**: Veterinary visits are where most pet medicines and tests are prescribed, so fewer or more visits move volume through clinics and into companies' pet revenue and diagnostics sales.
- **Livestock disease outbreaks**: Outbreaks raise demand for vaccines and treatments in livestock herds but can also cut animal numbers, so they shift the livestock revenue split and make it less predictable.
- **New parasiticide and dermatology launches**: A new product in a large category such as parasite control or skin disease can add sales quickly and lift gross margin, so launch uptake is tracked in organic growth by brand.

## Major Risks

- **Generic and compounded competition**: Cheaper copies and pharmacy-compounded versions pull volume and price from established brands; watch organic growth and gross margin in the affected product lines.
- **Pet-spending slowdowns**: When owners cut back on discretionary pet care, visits and elective purchases fall first, which appears as weaker clinic visit trends and slower pet revenue.
- **Regulatory approval timing**: A delayed or refused approval pushes launches back, so expected new-product revenue fails to arrive; watch the pipeline of approvals and company timing guidance.
- **Livestock price cycles**: Livestock customers buy fewer products when animal or protein prices fall and margins shrink, which weighs on livestock revenue and organic growth.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. / Global |

## Companies Associated with Animal Health

The SEC's Standard Industrial Classification has no code that describes animal health as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.

| Company | SEC classification | Revenue | Growth | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Zoetis Inc.](https://www.getswoopr.com/stocks/companies/zoetis/) | Pharmaceutical Preparations | $9.5 billion | 2.3% | 28.2% | FY 2025 |
| [Elanco Animal Health Inc](https://www.getswoopr.com/stocks/companies/elanco-animal-health-incorporated/) | Pharmaceutical Preparations | $4.7 billion | 6.2% | -4.9% | FY 2025 |
| [Idexx Laboratories Inc](https://www.getswoopr.com/stocks/companies/idexx-laboratories/) | In Vitro & In Vivo Diagnostic Substances | $4.3 billion | 10.4% | 24.6% | FY 2025 |

Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the [company directory](https://www.getswoopr.com/stocks/companies/) and the [health care hub](https://www.getswoopr.com/stocks/industries/health-care/).

## Where to Go Next

The Animal Health guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Health Care

- [Health Care sector overview](https://www.getswoopr.com/stocks/industries/health-care/)
- [Antibody Therapeutics](https://www.getswoopr.com/stocks/industries/health-care/antibody-therapeutics/)
- [Ambulatory Surgery Centers](https://www.getswoopr.com/stocks/industries/health-care/ambulatory-surgery-centers/)
- [Behavioral Health Providers](https://www.getswoopr.com/stocks/industries/health-care/behavioral-health-providers/)
- [Wound Care](https://www.getswoopr.com/stocks/industries/health-care/wound-care/)
- [Bioinformatics](https://www.getswoopr.com/stocks/industries/health-care/bioinformatics/)
- [Women's Health Pharmaceuticals](https://www.getswoopr.com/stocks/industries/health-care/women-s-health-pharmaceuticals/)
- [Biopharma Manufacturing Equipment](https://www.getswoopr.com/stocks/industries/health-care/biopharma-manufacturing-equipment/)
- [Veterinary Services](https://www.getswoopr.com/stocks/industries/health-care/veterinary-services/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Animal Health industry?

Key performance indicators for the Animal Health industry include: Revenue split between pet and livestock, Organic growth in key brands, Vet clinic visit trends, Gross margin, Pipeline of new approvals. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Animal Health industry?

The Animal Health industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.

What are the biggest risks in the Animal Health industry?

The primary risks for Animal Health companies include: Generic and compounded competition, Pet-spending slowdowns, Regulatory approval timing, Livestock price cycles. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).